Anti-Cancer Drugs
About
The 4.4k papers published in Anti-Cancer Drugs in the last decades have received a total of 81.5k indexed citations.
Papers published in Anti-Cancer Drugs usually cover Oncology (2.1k papers), Molecular Biology (2.0k papers) and Pulmonary and Respiratory Medicine (895 papers) specifically the topics of Cancer therapeutics and mechanisms (477 papers), Cancer Treatment and Pharmacology (477 papers) and Colorectal Cancer Treatments and Studies (370 papers). The most active scholars publishing in Anti-Cancer Drugs are Ian A. Cree, Jos H. Beijnen, Daniel D. Von Hoff, Alex Sparreboom and Jaap Verweij.
In The Last Decade
Fields of papers published in Anti-Cancer Drugs
Since SpecializationEngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
Countries where authors publish in Anti-Cancer Drugs
Since SpecializationTotal citations of papers
Explore journals with similar magnitude of impact
Breakdown of academic impact, for papers in Journal of Propulsion and Power Breakdown of academic impact, for papers in BMC Medical Informatics and Decision Making Breakdown of academic impact, for papers in International Journal of Modern Physics D Breakdown of academic impact, for papers in Royal Society Open Science Breakdown of academic impact, for papers in Journal of Molecular Neuroscience Breakdown of academic impact, for papers in Transplant International Breakdown of academic impact, for papers in ChemElectroChem Breakdown of academic impact, for papers in Genetic Resources and Crop Evolution